514 related articles for article (PubMed ID: 15878061)
41. Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis.
Tan CS; Wong HK; Yang FP; Lee JJ
Eye (Lond); 2008 Jan; 22(1):150-1. PubMed ID: 17962826
[TBL] [Abstract][Full Text] [Related]
42. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
[TBL] [Abstract][Full Text] [Related]
43. 25-Gauge pars plana vitrectomy for retained lens fragments.
Ho LY; Walsh MK; Hassan TS
Retina; 2010 Jun; 30(6):843-9. PubMed ID: 20531141
[TBL] [Abstract][Full Text] [Related]
44. Removal of silicone oil with 25-gauge transconjunctival sutureless vitrectomy system.
Kapran Z; Acar N
Retina; 2007 Oct; 27(8):1059-64. PubMed ID: 18040245
[TBL] [Abstract][Full Text] [Related]
45. Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes.
Schiff WM; Barile GR; Hwang JC; Tseng JJ; Cekiç O; Del Priore LV; Chang S
Ophthalmology; 2007 Mar; 114(3):544-50. PubMed ID: 17169431
[TBL] [Abstract][Full Text] [Related]
46. 23-gauge transconjunctival sutureless vitrectomy: visual outcomes and complications.
Mateo-Montoya A; Mendrinos E; Tabatabay C; Pournaras CJ
Semin Ophthalmol; 2011 Mar; 26(2):37-41. PubMed ID: 21469961
[TBL] [Abstract][Full Text] [Related]
47. Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery.
Sharma T; Sinha S; Shah N; Gopal L; Shanmugam MP; Bhende P; Bhende M; Shetty NS; Agrawal R; Deshpande D; Biswas J; Sukumar B
Ophthalmology; 2003 May; 110(5):996-1004. PubMed ID: 12750103
[TBL] [Abstract][Full Text] [Related]
48. 25-Gauge transconjunctival sutureless pars plana vitrectomy.
Yanyali A; Celik E; Horozoglu F; Oner S; Nohutcu AF
Eur J Ophthalmol; 2006; 16(1):141-7. PubMed ID: 16496259
[TBL] [Abstract][Full Text] [Related]
49. Surgical outcomes of 25-gauge transconjunctival vitrectomy combined with cataract surgery for vitreoretinal diseases.
Oshima Y; Ohji M; Tano Y
Ann Acad Med Singap; 2006 Mar; 35(3):175-80. PubMed ID: 16625266
[TBL] [Abstract][Full Text] [Related]
50. Vitreoretinal surgery using transconjunctival sutureless vitrectomy.
Cho YJ; Lee JM; Kim SS
Yonsei Med J; 2004 Aug; 45(4):615-20. PubMed ID: 15344201
[TBL] [Abstract][Full Text] [Related]
51. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery.
Fujii GY; De Juan E; Humayun MS; Chang TS; Pieramici DJ; Barnes A; Kent D
Ophthalmology; 2002 Oct; 109(10):1814-20. PubMed ID: 12359600
[TBL] [Abstract][Full Text] [Related]
52. Removal of Densiron-68 with a 23-gauge transconjunctival vitrectomy system.
Romano MR; Groenwald C; Das R; Stappler T; Wong D; Heimann H
Eye (Lond); 2009 Mar; 23(3):715-7. PubMed ID: 19151654
[TBL] [Abstract][Full Text] [Related]
53. Transconjunctival drainage of serous and hemorrhagic choroidal detachment.
Rezende FA; Kickinger MC; Li G; Prado RF; Regis LG
Retina; 2012 Feb; 32(2):242-9. PubMed ID: 22127221
[TBL] [Abstract][Full Text] [Related]
54. Bacterial contamination of the vitreous cavity associated with transconjunctival 25-gauge microincision vitrectomy surgery.
Tominaga A; Oshima Y; Wakabayashi T; Sakaguchi H; Hori Y; Maeda N
Ophthalmology; 2010 Apr; 117(4):811-7.e1. PubMed ID: 20097429
[TBL] [Abstract][Full Text] [Related]
55. Comparison of one-year outcomes between 23- and 20-gauge vitrectomy for preretinal membrane.
Hikichi T; Matsumoto N; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R
Am J Ophthalmol; 2009 Apr; 147(4):639-643.e1. PubMed ID: 19152868
[TBL] [Abstract][Full Text] [Related]
56. Transconjunctival mitomycin-C in needle revisions of failing filtering blebs.
Iwach AG; Delgado MF; Novack GD; Nguyen N; Wong PC
Ophthalmology; 2003 Apr; 110(4):734-42. PubMed ID: 12689895
[TBL] [Abstract][Full Text] [Related]
57. Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification.
Chang CJ; Chiang SY; Chen CL; Wang TY
J Cataract Refract Surg; 2006 Dec; 32(12):2054-9. PubMed ID: 17137983
[TBL] [Abstract][Full Text] [Related]
58. SURGICAL OUTCOMES OF 27-GAUGE VITRECTOMY FOR A CONSECUTIVE SERIES OF 163 EYES WITH VARIOUS VITREOUS DISEASES.
Yoneda K; Morikawa K; Oshima Y; Kinoshita S; Sotozono C;
Retina; 2017 Nov; 37(11):2130-2137. PubMed ID: 28590319
[TBL] [Abstract][Full Text] [Related]
59. Long-term safety and functional outcome of combined pars plana vitrectomy and scleral-fixated sutured posterior chamber lens implantation.
Bading G; Hillenkamp J; Sachs HG; Gabel VP; Framme C
Am J Ophthalmol; 2007 Sep; 144(3):371-377. PubMed ID: 17624290
[TBL] [Abstract][Full Text] [Related]
60. Familial exudative vitreoretinopathy. Results of surgical management.
Pendergast SD; Trese MT
Ophthalmology; 1998 Jun; 105(6):1015-23. PubMed ID: 9627651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
